GENEDRIVE PLC – Board Appointments
RNS Number : 5840R Genedrive PLC 21 August 2026 21 August 2026 genedrive plc (“genedrive” or the “Company”)
RNS Number : 5840R Genedrive PLC 21 August 2026 21 August 2026 genedrive plc (“genedrive” or the “Company”)
RNS Number : 4505Q Genedrive PLC 13 August 2026 13 August 2026 genedrive plc (“genedrive” or the “Company”)
RNS Number : 0466Q Genedrive PLC 11 August 2026 11 August 2026 genedrive plc (“genedrive” or the “Company”)
RNS Number : 0842P Genedrive PLC 04 August 2026 4 August 2026 genedrive plc (“genedrive” or the “Company”)
RNS Number : 8376O Genedrive PLC 03 August 2026 3 August 2026 genedrive plc (“genedrive” or the “Company”)
RNS Number : 0177M Genedrive PLC 13 July 2026 13 July 2026 genedrive plc (“genedrive” or the “Company”)
RNS Number : 7791L Genedrive PLC 10 July 2026 10 July 2026 genedrive plc (“genedrive” or the “Company”)
RNS Number : 0755K Genedrive PLC 29 June 2026 29 June 2026 genedrive plc (“genedrive” or the “Company”)
RNS Number : 5382Y Genedrive PLC 30 March 2026 30 March 2026 genedrive plc (“genedrive” or the “Company”) Interim
genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces unaudited interim results for the six months to 31 December 2019.